GAD-specific T cells are induced by GAD-alum treatment in Type-1 diabetes patients

Pihl, M; Barcenilla, H; Axelsson, S; Cheramy, M; Akerman, L; Johansson, I; Ludvigsson, J; Casas, R

Barcenilla, H (reprint author), Linkoping Univ, Fac Med, KEF Floor 10, S-58185 Linkoping, Sweden.

CLINICAL IMMUNOLOGY, 2017; 176 ( ): 114

Abstract

Administration of Glutamic Acid Decarboxylase (GAD)(65) formulated in aluminium hydroxide preserved insulin secretion in a phase II trial in recent on......

Full Text Link